From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
-
Published:2020-09-15
Issue:3
Volume:22
Page:511-525
-
ISSN:1389-9155
-
Container-title:Reviews in Endocrine and Metabolic Disorders
-
language:en
-
Short-container-title:Rev Endocr Metab Disord
Author:
Vitale GiovanniORCID, Dicitore AlessandraORCID, Barrea LuigiORCID, Sbardella EmiliaORCID, Razzore PaolaORCID, Campione SeveroORCID, Faggiano AntongiulioORCID, Colao AnnamariaORCID, Albertelli Manuela, Altieri Barbara, Bottiglieri Filomena, De Cicco Federica, Di Molfetta Sergio, Fanciulli Giuseppe, Feola Tiziana, Ferone Diego, Ferraù Francesco, Gallo Marco, Giannetta Elisa, Grillo Federica, Grossrubatscher Erika, Guadagno Elia, Guarnotta Valentina, Isidori Andrea M., Lania Andrea, Lenzi Andrea, Calzo Fabio Lo, Malandrino Pasquale, Messina Erika, Modica Roberta, Muscogiuri Giovanna, Pes Luca, Pizza Genoveffa, Pofi Riccardo, Puliani Giulia, Rainone Carmen, Rizza Laura, Rubino Manila, Ruggieri Rosa Maria, Sesti Franz, Venneri Mary Anna, Zatelli Maria Chiara,
Abstract
AbstractGut microbiota is represented by different microorganisms that colonize the intestinal tract, mostly the large intestine, such as bacteria, fungi, archaea and viruses. The gut microbial balance has a key role in several functions. It modulates the host’s metabolism, maintains the gut barrier integrity, participates in the xenobiotics and drug metabolism, and acts as protection against gastro-intestinal pathogens through the host’s immune system modulation. The impaired gut microbiota, called dysbiosis, may be the result of an imbalance in this equilibrium and is linked with different diseases, including cancer. While most of the studies have focused on the association between microbiota and gastrointestinal adenocarcinomas, very little is known about gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs). In this review, we provide an overview concerning the complex interplay between gut microbiota and GEP NENs, focusing on the potential role in tumorigenesis and progression in these tumors.
Funder
Università degli Studi di Milano
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference191 articles.
1. Muscogiuri G, Balercia G, Barrea L, Cignarelli A, Giorgino F, Holst JJ, et al. Gut: a key player in the pathogenesis of type 2 diabetes? Crit Rev Food Sci Nutr. 2018;24:1294–309. 2. Barrea L, Muscogiuri G, Annunziata G, Laudisio D, Pugliese G, Salzano C, et al. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course? Hormones (Athens). 2019;18:245–50. 3. Zhang YL, Li S, Gan RY, Zhou T, Xu DP, Li HB. Impacts of gut bacteria on human health and diseases. Int J Mol Sci. 2015;4:7493–519. 4. Feng Q, Chen WD, Wang YD. Gut microbiota: an integral moderator in health and disease. Front Microbiol. 2018;9:151. 5. Kong F, Cai Y. Study insights into gastrointestinal cancer through the gut microbiota. Biomed Res Int. 2019;3:1–8.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|